Answers are grounded in this paper and cite their sources.
Small cell prostate carcinoma is a lethal variant of castration-resistant prostate cancer. Beltran and colleagues identified overexpression and amplification of both aurora kinase A (AURKA) and the MYCN proto-oncogene in the small cell prostate carcinomas and propose Aurora kinase A as a potential therapeutic target in this disease subset. Cancer Discovery; 1(6); 466–68.
No takes yet. Share an insight, caveat, or question.
Aparicio et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: